Adaptimmune shares rise on mid-stage cancer trial data ahead of ASCO21
21 May 2021 - 1:14AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From Apr 2024 to May 2024
Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From May 2023 to May 2024